MAXIMUS (MMS) Numbers Trimmed at Jefferies But 'Buy' Maintained Posts Q4
- Top 10 News for 12/2: Crude Rips on OPEC Cut; Starbucks' Schultz Steps Down; Nonfarm Payrolls Flat in Nov.
- Unemployment Rate Drops to 4.6%
- Bond yields slip on U.S. jobs data, euro steady before Italy vote
- Alibaba (BABA) Founder Jack Ma Discuss Plans to Retire; 'I Don't Want to Die at the Office'
- Starbucks Coffee (SBUX) CEO Howard Schultz to Step Down, Appointed Executive Chairman; Kevin Johnson New CEO
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
Jefferies analyst David Styblo trimmed estimates and his price target on MAXIMUS, Inc. (NYSE: MMS) to $65.00 (from $67.00) but maintained a Buy rating noting 4 key insights from the company's Q4.
Styblo commented, "This week's V-shaped recovery seems appropriate to us as fears of losing ACA related revenue are less than than initially expected. In a worst case, we estimate ~20c of total EPS risk. However, in a repeal and replace scenario, MMS would likely be relatively immune and could actually benefit from more work being conducted at the state level. Aside from this, the pipeline remains strong."
1. ACA Exposure Less Than Feared
2. Repeal and Replace Could Bring New Opportunities.
3. Pipeline Continues to Look Healthy
4. FY2017 Guidance Brackets Consensus.
The firm lowered FY 2017 EPS from $3.15 to $3.02.
Shares of MAXIMUS, Inc. closed at $52.02 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies Cuts Price Target on Workday (WDAY) to $71 Following 3Q
- Jefferies Raises Price Target on US Physical Therapy (USPH) to $63 Following 12-Clinic Acquisition
- Jefferies Cuts Price Target on Kroger (KR) to $30 Following 3Q and Guidance
Create E-mail Alert Related CategoriesAnalyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change
Related EntitiesJefferies & Co
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!